Skip to main content

Table 2 Comparison of Spill Kit Usage Before and After the Medical Safety Training Session (n = 72)

From: Managing adherence, exposure, and toxicity in oral anticancer therapies

 

Before the workshop (May 2017—September 2017)

n = 24

After the workshop (October 2017—February 2018)

n = 18

P-value

Department used

 Hospital wards

19 (79.2%)

15 (83.3%)

 

 Outpatient

3 (12.5%)

3 (16.7%)

 Pharmaceutical department

2 (8.3%)

0

Location of use

 Around the bed

13 (54.2%)

11 (61.1%)

 

 Toilet and washbasin

4 (16.6%)

6 (33.3%)

 Treatment room

4 (16.6%)

1 (5.5%)

 Pharmaceutical department

2 (8.3%)

0

 Corridors and visiting rooms

1 (4.2%)

0

Spill content

 Anticancer drug

12 (50.0%)

5 (27.7%)

 

 Urine

7 (29.1%)

7 (38.8%)

 Stool

4 (16.6%)

4 (22.2%)

 Emesma

1 (4.2%)

2 (11.1%)

Occupation

 Physician

0

1 (5.5%)

 

 Nurse

22 (91.6%)

17 (94.4%)

 Pharmacist

2 (8.3%)

0

Years of Occupational Experience

 More than 5 years

9 (37.5%)

9 (50.0%)

 

Compliance with personal protective equipment

 Gloves

24 (100%)

18 (100%)

 > 0.99

 Gown

24 (100%)

18 (100%)

 > 0.99

 N95 mask

18 (75.0%)

18 (100%)

0.026

 Cap

23 (95.8%)

18 (100%)

0.571

 Shoe cover

22 (91.6%)

18 (100%)

0.321

 Goggles

21 (87.5%)

18 (100%)

0.176

 Water absorbent sheet

23 (95.8%)

17 (94.4%)

0.571

 Towel

24 (100%)

18 (100%)

 > 0.99

Compliance with inactivators and detergents

 Sodium hypochlorite

24 (100%)

24 (100%)

 > 0.99

 Detergent (surfactant)

24 (100%)

24 (100%)

 > 0.99